In the rapidly evolving landscape of nutraceuticals, Pomella Extract—a proprietary, standardized extract of pomegranate rich in punicalagins—has emerged as a gold standard. Unlike generic pomegranate extracts, high-quality Pomella is distinguished by its standardized potency, ensuring that consumers receive a consistent, clinically validated dose of polyphenols.
The global demand for pomegranate-derived ingredients is driven by the "healthy aging" and "nutricosmetics" sectors. Current market data indicates a surge in demand for extracts with high bioavailability. Industry leaders are pivoting towards full-spectrum extraction technologies that preserve the synergy of punicalagins, ellagic acid, and other bioactive compounds.
China has solidified its position as the global hub for botanical extraction through aggressive investment in R&D and automated production lines.
Efficiency & Scalability: Leading factories, such as those collaborating with our R&D initiatives, utilize high-capacity supercritical CO2 extraction and membrane filtration technologies. This not only ensures high purity (standardized to 30%-50% punicalagins) but also reduces production costs, allowing for competitive pricing for international procurement.
The versatility of Pomella Extract allows it to transcend traditional capsules. We are seeing a massive shift toward:
Pomella is a standardized extract focusing on punicalagins (A & B) and their metabolism into urolithins. Generic powders often lack specific concentration levels, making therapeutic dosing unreliable.
We employ ISO-certified testing protocols, including HPLC (High-Performance Liquid Chromatography) analysis to verify exact punicalagin percentages in every batch.
Due to our vertically integrated supply chain, we maintain strategic inventory for raw materials, allowing us to process bulk orders (100kg+) within 2-4 weeks.
Chenlv Herb
